SMTC Corp. (SMTC) Sees Q3 as Weakest Qtr., Boosts Q4 EBITDA Expectations, Intros FY12 Expectations
Tweet
Share
E-mailGet Alerts SMTX Hot Sheet
Price: $6.04 --0%
Financial Fact:
Net earnings (loss), also being comprehensive income (loss): -19K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net earnings (loss), also being comprehensive income (loss): -19K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
SMTC Corporation (Nasdaq: SMTX) today provided a Q3, Q4, and 2012 business update.
"In an effort to offer increased transparency about the business to our shareholders, we are providing the following update about our expected Q3, Q4 and 2012 results. We continue to expect Q3 to be our weakest quarter of the year, and anticipate generating $825,000 in EBITDA for the quarter. However, due to new program wins from both current and new customers, recent cost reduction initiatives, and our recent acquisition, we now expect the business to generate $4.0 million in EBITDA in Q4, up from our prior guidance of $3.0 million," stated Claude Germain, Co-Chief Executive Officer. "Barring additional major macroeconomic changes and based on forecasts from our customers as well as our internal forecasts, we are also introducing a 2012 EBITDA guidance of $13 million in EBITDA and $240 million in revenues."
"In an effort to offer increased transparency about the business to our shareholders, we are providing the following update about our expected Q3, Q4 and 2012 results. We continue to expect Q3 to be our weakest quarter of the year, and anticipate generating $825,000 in EBITDA for the quarter. However, due to new program wins from both current and new customers, recent cost reduction initiatives, and our recent acquisition, we now expect the business to generate $4.0 million in EBITDA in Q4, up from our prior guidance of $3.0 million," stated Claude Germain, Co-Chief Executive Officer. "Barring additional major macroeconomic changes and based on forecasts from our customers as well as our internal forecasts, we are also introducing a 2012 EBITDA guidance of $13 million in EBITDA and $240 million in revenues."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- loanDepot receives NYSE non-compliance notice over stock price
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
